TCL Archive In Brief: Univ. of New Mexico Looked Over As Possible Comprehensive Center; Missouri Asks Delay November 26, 1976
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive In Brief: Yarbro To Leave As NCI Centers Chief to Head Missouri Cancer Program; Replaced By Cantril May 30, 1975
TCL Archive Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial March 28, 2014
